Contraceptives Market (By Product: Drugs [Oral contraceptive pills, Injectable contraceptives, Topical contraceptives], Devices [Condoms {Male condoms, Female condoms} Diaphragms, Contraceptive sponges, Vaginal rings, Subdermal implants, Intra-uterine devices {Copper IUD, Hormonal IUD}]; By Age: 15-19, 20-29, 30-39, 40-49) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 160

CHAPTER 1. Industry Overview

1.1. Definition and Scope
       1.1.1. Definition of Contraceptives
       1.1.2. Market Segmentation
       1.1.3. List of Abbreviations
1.2. Summary
       1.2.1. Market Snapshot
       1.2.2. Contraceptives Market By Product
                 1.2.2.1. Global Contraceptives Market Revenue and Growth Rate Comparison By Product (2015-2026)
                 1.2.2.2. Global Contraceptives Market Revenue Share By Product in 2017
                 1.2.2.3. Drugs
                              1.2.2.3.1. Oral contraceptive pills
                              1.2.2.3.2. Injectable contraceptives
                              1.2.2.3.3. Topical contraceptives
                 1.2.2.4. Devices
                              1.2.2.4.1. Condoms
                              1.2.2.4.2. Diaphragms
                              1.2.2.4.3. Contraceptive sponges
                              1.2.2.4.4. Vaginal rings
                              1.2.2.4.5. Subdermal implants
                              1.2.2.4.6. Intra-uterine devices
                 1.2.2.5. Others
       1.2.3. Contraceptives Market By Age
                 1.2.3.1. Global Contraceptives Market Revenue and Growth Rate Comparison By Age (2015-2026)
                 1.2.3.2. Global Contraceptives Market Revenue Share By Age in 2017
                 1.2.3.3. 15-19
                 1.2.3.4. 20-29
                 1.2.3.5. 30-39
                 1.2.3.6. 40-49
                 1.2.3.7. Others
       1.2.4. Contraceptives Market by Geography
                 1.2.4.1. Global Contraceptives Market Revenue and Growth Rate Comparison by Geography (2015-2026)
                 1.2.4.2. North America Contraceptives Market Revenue and Growth Rate (2015-2026)
                 1.2.4.3. Europe Contraceptives Market Revenue and Growth Rate (2015-2026)
                 1.2.4.4. Asia-Pacific Contraceptives Market Revenue and Growth Rate (2015-2026)
                 1.2.4.5. Latin America Contraceptives Market Revenue and Growth Rate (2015-2026)
                 1.2.4.6. Middle East and Africa (MEA) Contraceptives Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. Market Dynamics And Competition Analysis

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
       2.4.1. Bargaining Power of Suppliers
       2.4.2. Bargaining Power of Buyers
       2.4.3. Threat of Substitute
       2.4.4. Threat of New Entrants
       2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
       2.6.1. Raw Material and Suppliers
       2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
       2.8.1. Player Positioning Analysis
       2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. Manufacturing Plants Analysis

3.1. Capacity and Commercial Production Date of Global Contraceptives Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Contraceptives Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Contraceptives Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Contraceptives Major Manufacturers in 2017

CHAPTER 4. Contraceptives Market By Product

4.1. Global Contraceptives Revenue By Product
4.2. Drugs
       4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
       4.2.3. Oral contraceptive pills
       4.2.4. Injectable contraceptives
       4.2.5. Topical contraceptives
4.3. Devices
       4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
       4.3.3. Condoms
       4.3.4. Diaphragms
       4.3.5. Contraceptive sponges
       4.3.6. Vaginal rings
       4.3.7. Subdermal implants
       4.3.8. Intra-uterine devices
4.4. Others
       4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. Contraceptives Market By Age

5.1. Global Contraceptives Revenue By Age
5.2. 15-19
       5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. 20-29
       5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. 30-39
       5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. 40-49
       5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Others
       5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.6.2. Market Revenue And Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. North America Contraceptives Market By Country

6.1. North America Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
       6.3.1. U.S. Contraceptives Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       6.3.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
6.4. Canada
       6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       6.4.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
6.5. Mexico
       6.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       6.5.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)

CHAPTER 7. Europe Contraceptives Market By Country

7.1. Europe Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
       7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       7.3.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
7.4. Germany
       7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       7.4.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
7.5. France
       7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       7.5.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
7.6. Spain
       7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       7.6.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
7.7. Rest of Europe
       7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       7.7.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)

CHAPTER 8. Asia-Pacific Contraceptives Market By Country

8.1. Asia-Pacific Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
       8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       8.3.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
8.4. Japan
       8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       8.4.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
8.5. India
       8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       8.5.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
8.6. Australia
       8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       8.6.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
8.7. South Korea
       8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       8.7.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
       8.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       8.8.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)

CHAPTER 9. Latin America Contraceptives Market By Country

9.1. Latin America Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
       9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       9.3.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
9.4. Argentina
       9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       9.4.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
9.5. Rest of Latin America
       9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       9.5.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)

CHAPTER 10. Middle East Contraceptives Market By Country

10.1. Middle East Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
         10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         10.3.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
10.4. UAE
         10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         10.4.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
10.5. Rest of Middle East
         10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         10.5.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)

CHAPTER 11. Africa Contraceptives Market By Country

11.1. Africa Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
         11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         11.3.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
11.4. Egypt
         11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         11.4.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
11.5. Rest of Africa
         11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         11.5.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)

CHAPTER 12. Company Profile

12.1. Merck Co. Inc.
         12.1.1. Company Snapshot
         12.1.2. Overview
         12.1.3. Financial Overview
         12.1.4. Product Portfolio
         12.1.5. Key Developments
         12.1.6. Strategies
12.2. Mithra Pharmaceuticals
         12.2.1. Company Snapshot
         12.2.2. Overview
         12.2.3. Financial Overview
         12.2.4. Product Portfolio
         12.2.5. Key Developments
         12.2.6. Strategies
12.3. Teva Pharmaceutical Industries Ltd.
         12.3.1. Company Snapshot
         12.3.2. Overview
         12.3.3. Financial Overview
         12.3.4. Product Portfolio
         12.3.5. Key Developments
         12.3.6. Strategies
12.4. Cipla Inc.
         12.4.1. Company Snapshot
         12.4.2. Overview
         12.4.3. Financial Overview
         12.4.4. Product Portfolio
         12.4.5. Key Developments
         12.4.6. Strategies
12.5. Janssen Pharmaceutical Company
         12.5.1. Company Snapshot
         12.5.2. Overview
         12.5.3. Financial Overview
         12.5.4. Product Portfolio
         12.5.5. Key Developments
         12.5.6. Strategies
12.6. Pfizer Inc.
         12.6.1. Company Snapshot
         12.6.2. Overview
         12.6.3. Financial Overview
         12.6.4. Product Portfolio
         12.6.5. Key Developments
         12.6.6. Strategies
12.7. Allergan plc
         12.7.1. Company Snapshot
         12.7.2. Overview
         12.7.3. Financial Overview
         12.7.4. Product Portfolio
         12.7.5. Key Developments
         12.7.6. Strategies
12.8. Mankind Pharma
         12.8.1. Company Snapshot
         12.8.2. Overview
         12.8.3. Financial Overview
         12.8.4. Product Portfolio
         12.8.5. Key Developments
         12.8.6. Strategies
12.9. Bayer AG
         12.9.1. Company Snapshot
         12.9.2. Overview
         12.9.3. Financial Overview
         12.9.4. Product Portfolio
         12.9.5. Key Developments
         12.9.6. Strategies
12.10. HLL Lifecare Limited
           12.10.1. Company Snapshot
           12.10.2. Overview
           12.10.3. Financial Overview
           12.10.4. Product Portfolio
           12.10.5. Key Developments
           12.10.6. Strategies
12.11. Reckitt Benckiser plc.
           12.11.1. Company Snapshot
           12.11.2. Overview
           12.11.3. Financial Overview
           12.11.4. Product Portfolio
           12.11.5. Key Developments
           12.11.6. Strategies
12.12. Others
           12.12.1. Company Snapshot
           12.12.2. Overview
           12.12.3. Financial Overview
           12.12.4. Product Portfolio
           12.12.5. Key Developments
           12.12.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
         13.1.1. Initial Data Search
         13.1.2. Secondary Research
         13.1.3. Primary Research
13.2. Assumptions and Scope

Cart Summary